The Company was founded in 2008 by a group of Polish medical doctors and scientists who have developed a breakthrough method of using liquid crystals for diagnosing breast cancer. The researchers have created a unique mixture of liquid crystal compounds and an innovative liquid crystal emulsion formula that has been used to develop a signature method of manufacturing liquid crystal matrices using Continuous Liquid Crystals Film (CLCF) technology. The objective of the Company’s activities is the roll-out of the BRASTER SYSTEM, an innovative, worldwide-unique device for support women in early detection of breast cancer symptoms.
